Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in DCIS
Release Date:
Interview with Seema A. Khan, MD, author of Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ: A Randomized Clinical Trial. Hosted by Amalia Cochran, MD. Related Content: Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ
Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in DCIS